Corioblastoma; Tumor trofoblástico; Corioepitelioma; Mola invasiva/maligna; Enfermedad trofoblástica gestacional; Neoplasia trofoblástica gestacional
Aunque el monitoreo cuidadoso de la mujer después de la extirpación de la mola hidatiforme o tras el final de un embarazo no puede prevenir el desarrollo del coriocarcinoma, es esencial para la identificación temprana de la afección, lo cual mejora los resultados.
![]() | A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |